BACKGROUND: Genome-wide expression analysis using microarrays has been used as a research strategy to discovery new biomarkers and candidate genes for a number of diseases. We aim to find new biomarkers for the prediction of acute coronary syndrome (ACS) with a differentially expressed mRNA profiling approach using whole genomic expression analysis in a peripheral blood cell model from patients with early ACS. METHODS AND RESULTS: This study was carried out in two phases. On phase 1 a restricted clinical criteria (ACS-Ph1, n=9 and CG-Ph1, n=6) was used in order to select potential mRNA biomarkers candidates. A subsequent phase 2 study was performed using selected phase 1 markers analyzed by RT-qPCR using a larger and independent casuistic (ACS-Ph2, n=74 and CG-Ph2, n=41). A total of 549 genes were found to be differentially expressed in the first 48 h after the ACS-Ph1. Technical and biological validation further confirmed that ALOX15, AREG, BCL2A1, BCL2L1, CA1, COX7B, ECHDC3, IL18R1, IRS2, KCNE1, MMP9, MYL4 and TREML4, are differentially expressed in both phases of this study. CONCLUSIONS: Transcriptomic analysis by microarray technology demonstrated differential expression during a 48 h time course suggesting a potential use of some of these genes as biomarkers for very early stages of ACS, as well as for monitoring early cardiac ischemic recovery.
BACKGROUND: Genome-wide expression analysis using microarrays has been used as a research strategy to discovery new biomarkers and candidate genes for a number of diseases. We aim to find new biomarkers for the prediction of acute coronary syndrome (ACS) with a differentially expressed mRNA profiling approach using whole genomic expression analysis in a peripheral blood cell model from patients with early ACS. METHODS AND RESULTS: This study was carried out in two phases. On phase 1 a restricted clinical criteria (ACS-Ph1, n=9 and CG-Ph1, n=6) was used in order to select potential mRNA biomarkers candidates. A subsequent phase 2 study was performed using selected phase 1 markers analyzed by RT-qPCR using a larger and independent casuistic (ACS-Ph2, n=74 and CG-Ph2, n=41). A total of 549 genes were found to be differentially expressed in the first 48 h after the ACS-Ph1. Technical and biological validation further confirmed that ALOX15, AREG, BCL2A1, BCL2L1, CA1, COX7B, ECHDC3, IL18R1, IRS2, KCNE1, MMP9, MYL4 and TREML4, are differentially expressed in both phases of this study. CONCLUSIONS: Transcriptomic analysis by microarray technology demonstrated differential expression during a 48 h time course suggesting a potential use of some of these genes as biomarkers for very early stages of ACS, as well as for monitoring early cardiac ischemic recovery.
Authors: J Sánchez; C Picó; W Ahrens; R Foraita; A Fraterman; L A Moreno; P Russo; A Siani; A Palou Journal: Int J Obes (Lond) Date: 2017-06-06 Impact factor: 5.095
Authors: Andrew J Schork; Yunpeng Wang; Rahul S Desikan; Wesley K Thompson; Abbas Dehghan; Paul M Ridker; Daniel I Chasman; Linda K McEvoy; Dominic Holland; Chi-Hua Chen; David S Karow; James B Brewer; Christopher P Hess; Julie Williams; Rebecca Sims; Michael C O'Donovan; Seung Hoan Choi; Joshua C Bis; M Arfan Ikram; Vilmundur Gudnason; Anita L DeStefano; Sven J van der Lee; Bruce M Psaty; Cornelia M van Duijn; Lenore Launer; Sudha Seshadri; Margaret A Pericak-Vance; Richard Mayeux; Jonathan L Haines; Lindsay A Farrer; John Hardy; Ingun Dina Ulstein; Dag Aarsland; Tormod Fladby; Linda R White; Sigrid B Sando; Arvid Rongve; Aree Witoelar; Srdjan Djurovic; Bradley T Hyman; Jon Snaedal; Stacy Steinberg; Hreinn Stefansson; Kari Stefansson; Gerard D Schellenberg; Ole A Andreassen; Anders M Dale Journal: Circulation Date: 2015-04-10 Impact factor: 29.690
Authors: John D Eicher; Yoshiyuki Wakabayashi; Olga Vitseva; Nada Esa; Yanqin Yang; Jun Zhu; Jane E Freedman; David D McManus; Andrew D Johnson Journal: Platelets Date: 2015-09-14 Impact factor: 3.862
Authors: Shurjo K Sen; Kimberly C Boelte; Jennifer J Barb; Roby Joehanes; XiaoQing Zhao; Qi Cheng; Lila Adams; Jamie K Teer; David S Accame; Soma Chowdhury; Larry N Singh; Maryam Kavousi; Patricia A Peyser; Laura Quigley; Debra Long Priel; Karen Lau; Douglas B Kuhns; Teizo Yoshimura; Andrew D Johnson; Shih-Jen Hwang; Marcus Y Chen; Andrew E Arai; Eric D Green; James C Mullikin; Frank D Kolodgie; Christopher J O'Donnell; Renu Virmani; Peter J Munson; Daniel W McVicar; Leslie G Biesecker Journal: Am J Hum Genet Date: 2014-06-26 Impact factor: 11.025
Authors: Zaida G Ramirez-Ortiz; Amit Prasad; Jason W Griffith; William F Pendergraft; Glenn S Cowley; David E Root; Melissa Tai; Andrew D Luster; Joseph El Khoury; Nir Hacohen; Terry K Means Journal: Nat Immunol Date: 2015-04-06 Impact factor: 25.606
Authors: Sajjad Rafiq; Sofia Khan; William Tapper; Andrew Collins; Rosanna Upstill-Goddard; Susan Gerty; Carl Blomqvist; Kristiina Aittomäki; Fergus J Couch; Jianjun Liu; Heli Nevanlinna; Diana Eccles Journal: PLoS One Date: 2014-12-19 Impact factor: 3.240
Authors: Olga M Pena; David G Hancock; Ngan H Lyle; Adam Linder; James A Russell; Jianguo Xia; Christopher D Fjell; John H Boyd; Robert E W Hancock Journal: EBioMedicine Date: 2014-11-01 Impact factor: 8.143